Navigation Links
Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
Date:1/17/2013

velopment of drug resistance.  By addressing this unmet medical need, the Hemopurifier® is positioned as an adjunct to improve established cancer treatment regimens.

Certain statements herein may be forward-looking and involve risks and uncertainties.  Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating from either compassionate use or non-compassionate use of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether a
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical (AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma
2. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
3. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
4. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
5. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
6. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
7. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
8. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
9. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
10. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
11. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17 2014 IBM (NYSE: IBM ) ... IBM technical computing and storage technology to accelerate ... These services deliver critically important information to help ... unique cancer, which could lead to better health ... in general. Today, optimal cancer care ...
(Date:9/17/2014)... , Switzerland , September 17, ... Debiopharm Group ™ , is proud to congratulate Biocartis ... instrument. Debiopharm Diagnostics is a long-time investor in ... Idylla ™ Biocartis, fully automated, real-time ... offer physicians fast and easy access to clinical ...
(Date:9/16/2014)... Sept. 16, 2014  ROX Medical today presented ... multi-center, prospective, randomized, controlled, blinded endpoint study of ... hypertension. The CONTROL-HTN trial, NCT01642498, evaluated the safety and ... connection between a central artery and vein in ... hypertension. The primary outcomes are reduction of blood ...
Breaking Medicine Technology:Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2ROX Medical presents positive data for CONTROL-HTN resistant hypertension trial 2
... Health Solutions, Inc. (NYSE: MHS ) will webcast its Annual Meeting ...  The presentations by David B. Snow Jr. , chairman and CEO, and ... , , ... Investor Relations section at www.medco.com/investor . The webcast will be available for ...
... May, AllerAir is supporting Multiple Chemical Sensitivities and Chemical Injury ...   , , , ... chemical awareness tips and a $50.00 gift certificate available via ... articles will be dedicated to Multiple Chemical Sensitivities ...
Cached Medicine Technology:Medco Announces Webcast for Annual Meeting of Shareholders 2Multiple Chemical Sensitivities Are Real 2Multiple Chemical Sensitivities Are Real 3
(Date:9/17/2014)... September 17, 2014 Kamut International is ... a key ingredient in Michael Angelo’s new “Made With ... new fully organic lasagna ready made, frozen meal. Michael ... pastas and these new products align well with Kamut ... all KAMUT® Brand wheat must be grown certified organic. ...
(Date:9/17/2014)... Promising new research published in the Journal ... the potential ability of ketones to support brain function ... study shows that brain hypometabolism associated with ... glucose uptake and/or utilization, and results suggest that increasing ... study, by the Research Center on Aging and Department ...
(Date:9/17/2014)... Right now no one can say whether yoga ... in a new article in the Journal of ... from scores of people with the condition who practice ... can be a substantial help, but it sometimes carries ... hatha yoga for bipolar disorder," said lead author Lisa ...
(Date:9/17/2014)... Fresh off their High Times Cannabis ... support of The Silver Tour, an educational non-profit effort ... benefits of medical marijuana. , Florida Buds, a Florida ... marijuana dispensary and treatment center, donated $1,000.00 to ... launch a statewide radio campaign in advance of Election ...
(Date:9/17/2014)... DMG Productions announces the upcoming airing ... broadcast on Wednesday, September 24, 2014 at 7:30 ... episode, Innovations will go behind the scenes to ... each client the opportunity to achieve the highest ... principles of Care, Compassion, and Commitment. , Audiences ...
Breaking Medicine News(10 mins):Health News:KAMUT® Brand Wheat Delivers a High Quality Ingredient and Authentic Italian Taste for Michael Angelo’s New Ready-Made Meals featuring Organic Ingredients 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Survey finds benefits, risks of yoga for bipolar disorder 2Health News:Survey finds benefits, risks of yoga for bipolar disorder 3Health News:Florida Buds Supports Silver Tour 2Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2
... becomes a job search engine with the functionality of a job board. ... ... the current economic woes, employment sites are experiencing an increase in the ... for new job openings, Fresho has changed its business concept from a ...
... Howard G. Smith,announces that a class action lawsuit has ... District of New Jersey against PharmaNet Development,Group, Inc. ("PharmaNet" ... behalf of all,persons who purchased or otherwise acquired the ... 2008. The complaint alleges that the Company,and certain of ...
... the,health insurance industry now have a dedicated community ... education coursework, and ensure best,practice application of research ... "We were looking for an ... there was no dedicated group for the health ...
... women need more culturally targeted information, study finds , , ... almost six times more likely than white women to ... breast cancer treatment, a new report says. , Researchers ... that despite being just as involved with their doctor ...
... Nov. 21 Album Creative Studios, Inc., a full-service brand ... for small businesses. , , ... services, and tailored them to small businesses with a very ... Creative , founded in 2002, combines experience and proven brand-building ...
... Health Science Center at Houston will launch a new ... geriatrics training for physicians through a prestigious $2 million ... million in matching funds., "This will allow us to ... junior medical student to practicing physicians. With the reach ...
Cached Medicine News:Health News:Fresho.com Adapts As The Online Recruiting Market Heats Up 2Health News:Law Offices of Howard G. Smith Announces Class Action Lawsuit on Behalf of Investors of PharmaNet Development Group, Inc. 2Health News:Society of Insurance Research and Fletcher/CSI Create First Forum for Research Professionals in the Health Insurance Industry 2Health News:Society of Insurance Research and Fletcher/CSI Create First Forum for Research Professionals in the Health Insurance Industry 3Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: